Popular Articles

U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial In Trauma Patients Remains On FDA Hold
Biopure Corporation (Nasdaq: BPUR) announced that the Food and Drug Administration has advised the U.S. Naval Medical Research Center (NMRC) by letter that it may not initiate a clinical trial of Biopure"s oxygen therapeutic Hemopure(R) [hemoglobin glutamer -- 250 (bovine)] under a proposed protocol submitted to the FDA in March 2009. As previously announced, the study, "Restore Effective Survival in Shock" (RESUS) was first proposed and submitted to the FDA in 2005. The proposed trial was placed on clinical hold at that time. It has been resubmitted repeatedly in response to FDA comments and to address comments made by the FDA Blood Products Advisory Committee at an open meeting held in December 2006. Each subsequent submission, including the most recent, was placed on clinical hold.

DNA Computation Gets Logical At The Weizmann Institute Of Science
Biomolecular computers, made of DNA and other biological molecules, only exist today in a few specialized labs, remote from the regular computer user. Nonetheless, Tom Ran and Shai Kaplan, research students in the lab of Prof. Ehud Shapiro of the Weizmann Institute"s Biological Chemistry, and Computer Science and Applied Mathematics Departments have found a way to make these microscopic computing devices "user friendly," even while performing complex computations and answering complicated queries.
News of the day
BioCryst Pharmaceuticals Announces Presentation Of Forodesine Data At The 45th Annual Meeting Of The American Society Of Clinical Oncology
BioCryst Pharmaceuticals (Nasdaq: BCRX) announced long-term data from a Phase 2 study of forodesine, the Company"s lead oncology compound, in patients with cutaneous T-cell lymphoma (CTCL). The data will be presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held in Orlando, Florida from May 29-June 2. Forodesine is a transition-state analog inhibitor of purine nucleoside phosphorylase (PNP), a purine salvage pathway enzyme that is essential for the proliferation of T-cells and B-cells.
Diagnostics

Group Files Petition Over Enforcement Of Regulations In Adult Film Industry To Prevent Sexually Transmitted Diseases

The AIDS Healthcare Foundation last week filed a petition in Los Angeles County Superior Court asking "the court to order the Los Angeles County Department of Public Health to enforce regulations that require condom use in adult-film production or take other reasonable steps to stem the spread of disease," the Los Angeles Times reports (Yoshino, 7/17). In the petition, "the group claims that in the month since an actress tested positive for HIV, the county Department of Public Health has done little to address what it considers to be a serious health threat" (AP/San Jose Mercury News, 7/16). In a statement released last week, the department, said, "The county continues to strongly support state legislation and the regulatory role of the [California Division of Occupational Safety and Health] as the most appropriate means to regulate the practices in the adult-film industry that expose performers to unnecessary and preventable occupational risks of acquiring and transmitting these diseases," adding, "The department does not believe that litigation is the best means to deal with this issue" (Yoshino, 7/17). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):